Elaine Round is currently global head of toxicology at BAT, based in Southampton, U.K., where she leads the team responsible for safety assessments across product categories. Prior to her role with BAT, she held the role of vice president of scientific and regulatory affairs for vapor and oral submissions at Reynolds and spent the previous six years in roles relating to the development of premarket applications to the U.S. Food and Drug Administration for a variety of tobacco products. There, she led a team of scientists and regulatory experts whose primary responsibilities included the development of premarket tobacco product applications for electronic cigarettes and oral nicotine-containing products, and substantial equivalence (SE) reports and exemption from SE requests for oral tobacco products. Round’s previous experience at Reynolds includes design, oversight, and conduct of human studies to assess abuse liability and constituent exposures as they relate to individual health impact from use of tobacco and nicotine-containing products, including electronic cigarettes, snus, dissolvable tobacco products, nicotine gum, and cigarettes. She has been employed with BAT and Reynolds since 2008 and holds a Bachelor of Arts degree from Washington University in St. Louis and a Doctor of Philosophy degree in genetics from the University of Washington in Seattle.